Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cell pathway discovery holds potential for new anticancer treatments

Oct. 9, 1997

Sugen expands SU-101 clinical trials

Oct. 9, 1997

Results from phase I trials with ISIS-3521/CGP-64128A reported

Oct. 9, 1997

Pamidronate evaluated as potential therapy for bone cancer

Oct. 9, 1997

New antineoplastic cryptophycin derivatives

Oct. 9, 1997

Myriad discovers gene's role as tumor suppressor

Oct. 9, 1997

Epimmune issued U.S. patent for cancer therapeutic

Oct. 7, 1997

Merck & Co. focuses on farnesyltransferase inhibitors

Oct. 7, 1997

Kyowa Hakko's cytostatic agents progress in U.S. clinical trials

Oct. 6, 1997

Clinical pharmacokinetic study of panomifene described

Oct. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...